FDA Expands Flibanserin Approval to Postmenopausal Women With Hypoactive Sexual Desire Disorder
March 24, 2026
The FDA has recently granted expanded approval for flibanserin to t...
Read More
Sexual Dysfunction in Schizophrenia
October 9, 2023
Schizophrenia has high prevalence rates of sexual dysfunction; howe...
Read More
Bremelanotide Approved to Treat Hypoactive Sexual Desire Disorder
July 6, 2019
The U.S. Food and Drug Administration approved bremelanotide to t...
Read More
![]()
August News and New Research
August 1, 2015
Flibanserin approved for hypoactive sexual desire disorder, childh...
Read More
![]()
June News and New Research
June 1, 2015
LAI risperidone superior to oral risperidone in first-episode psyc...
Read More